Related Experiment Video
Updated: Jan 7, 2026

Combining 3D Magnetic Force Actuator and Multi-Functional Fluorescence Imaging to Study Nucleus Mechanobiology
Published on: July 5, 2022
Drug resistant cancer cells show increased nuclear mechanotransduction and mechanically targetable YAP-regulated
Miao Huang1, Yinong Chen2, Chenyu Liang1
1Department of Mechanical and Aerospace Engineering, Herbert Wertheim College of Engineering, University of Florida, Gainesville, FL, 32610, USA; UF Health Cancer Center, University of Florida, Gainesville, FL, 32610, USA.
Abstract:
Drug resistance is a leading cause of cancer treatment failure and tumor recurrence. Identifying new methods that eliminate life-threatening drug-resistant cancer cells (DRCs) can enhance tumor cell eradication and improve patient outcomes. Here we report that human non-small cell lung cancer (NSCLC) DRCs show previously unrecognized increased sensitivity to mechanical stimuli compared to drug-susceptible lung cancer cells (DSCs) in vitro. Exploiting this heightened mechanical sensitivity, the combination of physiologically soft culture microenvironment with targeted therapies reduces the survival of DRCs through regulating yes-associated-protein (YAP) translocation between nucleus and cytoplasm. Our clinical studies confirm that DRCs possess heightened YAP nuclear localization in both NSCLC patient-derived organoid models and patient tissues, indicating high potential of eradicating DRCs by mechanical stimuli in vivo. Further, our mechanistic analyses, including quantitative imaging, transcriptomic profiling, and pharmacological evaluations reveal that the alterations in nuclear force sensing, rather than actomyosin contractility or Hippo-YAP pathway activation in DRCs, primarily drive the heightened YAP mechanosensitivity. This work highlights the crucial difference in mechanosensitivity between DRCs and DSCs, and points to mechanobiological targeting of these cells as a novel strategy to overcome drug resistance and enhance cancer therapy.
Insights
Drug-resistant lung cancer cells are more sensitive to mechanical forces. Targeting this mechanosensitivity, particularly YAP nuclear localization, offers a new strategy to eliminate resistant cancer cells and improve treatment outcomes.
Area of Science:
- Oncology
- Mechanobiology
- Biophysics
Background:
- Drug resistance is a major challenge in cancer therapy, leading to treatment failure and recurrence.
- Developing novel strategies to eliminate drug-resistant cancer cells (DRCs) is crucial for improving patient outcomes.
- Non-small cell lung cancer (NSCLC) is a significant cause of cancer-related mortality.
Purpose of the Study:
- To investigate the mechanical sensitivity of drug-resistant NSCLC cells.
- To explore novel therapeutic strategies targeting the unique properties of DRCs.
- To elucidate the mechanisms underlying the heightened mechanosensitivity of DRCs.
Main Methods:
- In vitro mechanical stimulation assays comparing drug-resistant cancer cells (DRCs) and drug-susceptible cancer cells (DSCs).
- Quantitative imaging, transcriptomic profiling, and pharmacological evaluations to analyze cellular responses.
- Analysis of YAP (Yes-associated protein) translocation and nuclear localization in response to mechanical stimuli.
- In vivo studies using NSCLC patient-derived organoid models and patient tissues.
Main Results:
- DRCs exhibit significantly increased sensitivity to mechanical stimuli compared to DSCs.
- A soft culture microenvironment combined with targeted therapies reduces DRC survival by modulating YAP translocation.
- DRCs show heightened YAP nuclear localization in patient-derived organoids and tissues.
- Alterations in nuclear force sensing, not actomyosin contractility or Hippo-YAP pathway activation, drive YAP mechanosensitivity in DRCs.
Conclusions:
- Drug-resistant NSCLC cells possess a unique mechanosensitivity that can be therapeutically exploited.
- Targeting YAP mechanosensitivity presents a promising novel strategy to overcome drug resistance in NSCLC.
- This research opens new avenues for mechanobiological interventions in cancer therapy.
More Related Videos
09:55All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
Related Concept Videos
Treatment Resistant Cancers
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Tension Response at Adherens Junctions
α-Catenin as a Mechanosensory Protein
The α-catenin of adherens junctions is an allosteric protein with three VH (vinculin...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cell-matrix's Response to Mechanical Forces
Anchoring junctions mechanically attach a cell to the...